Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.

BiotechTV

November 11, 2026

BIO-Europe 2026: Epitopea has just started dosing patients in the first clinical trial of its RNA-based cancer vaccine

CEO Alan Rigby tells us about the program, and says data should start emerging next year.

Watch the full interview here.
Source: BiotechTV

Related News

Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2026 Epitopea Ltd | All Rights Reserved
Created by FDM Digital
arrow-down